These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 33981139)

  • 1. Biological Therapies in Children and Adolescents with Severe Uncontrolled Asthma: A Practical Review.
    Votto M; De Filippo M; Licari A; Marseglia A; De Amici M; Marseglia GL
    Biologics; 2021; 15():133-142. PubMed ID: 33981139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe asthma in children: Current goals and unmet needs.
    Licari A; Manti S; Chiappini E; Ciprandi G; Marseglia GL
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():40-42. PubMed ID: 32017220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic Therapy and Severe Asthma in Children.
    Russo D; Di Filippo P; Attanasi M; Lizzi M; Di Pillo S; Chiarelli F
    Biomedicines; 2021 Jun; 9(7):. PubMed ID: 34209312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of asthma endotypes and phenotypes.
    Taunk ST; Cardet JC; Ledford DK
    Allergy Asthma Proc; 2022 Sep; 43(5):375-382. PubMed ID: 36065106
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent Advances in Severe Asthma: From Phenotypes to Personalized Medicine.
    Schoettler N; Strek ME
    Chest; 2020 Mar; 157(3):516-528. PubMed ID: 31678077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma phenotypes and endotypes: a personalized approach to treatment.
    Skloot GS
    Curr Opin Pulm Med; 2016 Jan; 22(1):3-9. PubMed ID: 26574717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Needs for Systems Approaches to Better Treat Individuals With Severe Asthma: Predicting Phenotypes and Responses to Treatments.
    Colas L; Hassoun D; Magnan A
    Front Med (Lausanne); 2020; 7():98. PubMed ID: 32296705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future targeted therapies for severe asthma: Managing treatment with biologics based on phenotypes and biomarkers.
    Santus P; Saad M; Damiani G; Patella V; Radovanovic D
    Pharmacol Res; 2019 Aug; 146():104296. PubMed ID: 31173886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe, uncontrolled eosinophilic asthma: Where we are heading.
    Bernstein JA; Panettieri R
    J Asthma; 2019 May; 56(5):459-472. PubMed ID: 29718738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of biomarkers to identify phenotypes and endotypes of severeasthma.
    Carr TF; Kraft M
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):414-420. PubMed ID: 30059792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe uncontrolled asthma in children: practical approach on diagnosis and management.
    Castagnoli R; Marseglia A; Brambilla I; Marseglia GL; Licari A
    Minerva Pediatr; 2020 Jun; 72(3):196-205. PubMed ID: 32108455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypes and endotypes of adult asthma: Moving toward precision medicine.
    Kaur R; Chupp G
    J Allergy Clin Immunol; 2019 Jul; 144(1):1-12. PubMed ID: 31277742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severe asthma revisited by biologic therapies emergences].
    Guilleminault L; Didier A
    Presse Med; 2019 Mar; 48(3 Pt 1):310-321. PubMed ID: 30922670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypes and endotypes of uncontrolled severe asthma: new treatments.
    Campo P; Rodríguez F; Sánchez-García S; Barranco P; Quirce S; Pérez-Francés C; Gómez-Torrijos E; Cárdenas R; Olaguibel JM; Delgado J; ;
    J Investig Allergol Clin Immunol; 2013; 23(2):76-88; quiz 1 p. follow 88. PubMed ID: 23654073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside.
    Agache I; Sugita K; Morita H; Akdis M; Akdis CA
    Curr Allergy Asthma Rep; 2015 Jun; 15(6):29. PubMed ID: 26141574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. It's Time to Start Phenotyping Our Patients with Asthma.
    Duffey H; Anderson WC
    Immunol Allergy Clin North Am; 2019 Nov; 39(4):561-572. PubMed ID: 31563189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving phenotypes to endotypes: is precision medicine achievable in asthma?
    Bagnasco D; Passalacqua G; Caminati M; Heffler E; Menzella F; De Ferrari L; Riccio AM; Folli C; Canonica GW
    Expert Rev Respir Med; 2020 Feb; 14(2):163-172. PubMed ID: 31899999
    [No Abstract]   [Full Text] [Related]  

  • 18. Proteomics in asthma and COPD phenotypes and endotypes for biomarker discovery and improved understanding of disease entities.
    O'Neil SE; Lundbäck B; Lötvall J
    J Proteomics; 2011 Dec; 75(1):192-201. PubMed ID: 22037230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation in Pediatric Asthma.
    Licari A; Manti S; Castagnoli R; Marseglia A; Foiadelli T; Brambilla I; Marseglia GL
    Front Pediatr; 2019; 7():289. PubMed ID: 31355170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moving towards precision care for childhood asthma.
    Mokhallati N; Guilbert TW
    Curr Opin Pediatr; 2016 Jun; 28(3):331-8. PubMed ID: 27093356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.